Home > Qtrly Results > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Quarterly Results Analysis [Sep2025]

SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Quarterly Results

Consolidated Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Revenues ₹14,478 Cr ₹13,851 Cr ₹12,959 Cr ₹13,675 Cr ₹13,291 Cr ₹12,653 Cr ₹11,983 Cr ₹12,381 Cr
Expenses ₹10,382 Cr ₹9,779 Cr ₹9,534 Cr ₹9,666 Cr ₹9,481 Cr ₹9,045 Cr ₹8,948 Cr ₹9,028 Cr
Operating Income ₹4,097 Cr ₹4,073 Cr ₹3,425 Cr ₹4,009 Cr ₹3,811 Cr ₹3,608 Cr ₹3,035 Cr ₹3,352 Cr
Other Income ₹900 Cr ₹694 Cr ₹904 Cr ₹466 Cr ₹482 Cr ₹533 Cr ₹606 Cr ₹375 Cr
Interest ₹100 Cr ₹75 Cr ₹49 Cr ₹52 Cr ₹69 Cr ₹62 Cr ₹74 Cr ₹35 Cr
Depreciation ₹730 Cr ₹701 Cr ₹664 Cr ₹631 Cr ₹626 Cr ₹655 Cr ₹650 Cr ₹622 Cr
Profit Before Tax ₹4,168 Cr ₹3,173 Cr ₹3,254 Cr ₹3,476 Cr ₹3,598 Cr ₹3,424 Cr ₹2,816 Cr ₹3,000 Cr
Profit After Tax ₹3,137 Cr ₹2,303 Cr ₹2,161 Cr ₹2,918 Cr ₹3,031 Cr ₹2,871 Cr ₹2,667 Cr ₹2,568 Cr
EPS ₹13.00 ₹9.50 ₹8.96 ₹12.10 ₹12.67 ₹11.82 ₹11.06 ₹10.52
Industry Peers & Returns1W1M1Y
SUN PHARMACEUTICAL INDUSTRIES 2.8% 6.7% 2.8%
DIVIS LABORATORIES 1.9% -0.5% 6.9%
CIPLA 1.8% -3.2% 2.1%
TORRENT PHARMACEUTICALS 0.1% 3.4% 15.8%
DR REDDYS LABORATORIES 2.7% 0.4% 3.4%
MANKIND PHARMA 1.4% -7.9% -13%
ZYDUS LIFESCIENCES 1.7% -5.9% -1.6%
LUPIN 4.1% 6.4% 1.8%
AUROBINDO PHARMA 2.5% 10% 0.6%

SUN PHARMACEUTICAL INDUSTRIES Quarterly Revenues

Revenues
Q-o-Q

4.53 %

Y-o-Y

8.93 %

Quarters Revenues % Change
Sep2025 ₹14,478 Cr
4.53
Jun2025 ₹13,851 Cr
6.89
Mar2025 ₹12,959 Cr
-5.24
Dec2024 ₹13,675 Cr
2.89
Sep2024 ₹13,291 Cr
5.05
Jun2024 ₹12,653 Cr
5.59
Mar2024 ₹11,983 Cr
-3.21
Dec2023 ₹12,381 Cr -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Operating Profit

Operating Profit
Q-o-Q

0.59 %

Y-o-Y

7.50 %

Quarters Operating Profit % Change
Sep2025 ₹4,097 Cr
0.59
Jun2025 ₹4,073 Cr
18.91
Mar2025 ₹3,425 Cr
-14.57
Dec2024 ₹4,009 Cr
5.20
Sep2024 ₹3,811 Cr
5.63
Jun2024 ₹3,608 Cr
18.86
Mar2024 ₹3,035 Cr
-9.46
Dec2023 ₹3,352 Cr -
Operating Margins
Q-o-Q

-3.78 %

Y-o-Y

-1.33 %

Quarters Operating Margin% % Change
Sep2025 28.29%
-3.78
Jun2025 29.4%
11.24
Mar2025 26.43%
-9.86
Dec2024 29.32%
2.27
Sep2024 28.67%
0.56
Jun2024 28.51%
12.55
Mar2024 25.33%
-6.46
Dec2023 27.08% -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

36.24 %

Y-o-Y

3.51 %

Quarters Profit After Tax % Change
Sep2025 ₹3,137 Cr
36.24
Jun2025 ₹2,303 Cr
6.57
Mar2025 ₹2,161 Cr
-25.94
Dec2024 ₹2,918 Cr
-3.73
Sep2024 ₹3,031 Cr
5.55
Jun2024 ₹2,871 Cr
7.67
Mar2024 ₹2,667 Cr
3.84
Dec2023 ₹2,568 Cr -
PAT Margins
Q-o-Q

30.39 %

Y-o-Y

-4.96 %

Quarters PAT Margin(%) % Change
Sep2025 21.67 %
30.39
Jun2025 16.62 %
-0.30
Mar2025 16.67 %
-21.85
Dec2024 21.33 %
-6.45
Sep2024 22.8 %
0.48
Jun2024 22.69 %
1.98
Mar2024 22.25 %
7.28
Dec2023 20.74 % -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

36.84 %

Y-o-Y

2.60 %

Quarters EPS % Change
Sep2025 ₹13
36.84
Jun2025 ₹9.5
6.03
Mar2025 ₹8.96
-25.95
Dec2024 ₹12.1
-4.50
Sep2024 ₹12.67
7.19
Jun2024 ₹11.82
6.87
Mar2024 ₹11.06
5.13
Dec2023 ₹10.52 -

You may also like the below Video Courses